Table 1.

Descriptive statistics on study cohort (n=441 patients).

Characteristic	Median (5th and 95th percentile) or Percent
Age (years)	56 (44, 68)
Female	20.9%
AFP initial presentation (ng/mL)	15.5 (2, 569)
AFP at OLT (ng/mL)	19 (2, 437)
Lab MELD at OLT	13 (7, 27)
MELD Difference (HCC exception – Lab)	9.4 (0, 20)
Tumor size: initial presentation	2.5 cm (1, 4.9)
Tumor number: initial presentation	1 (0.8)
Tumor size: explant pathology	2.0 cm (0, 5)
Tumor number: explant pathology	1 (1.7)
Time from initial presentation to OLT	6.5 months (1.4, 39.1)
Etiology
Cryptogenic	5.0%
ETOH	8.8%
HBV	7.7%
HCV	69.0 %
NASH	5.4%
PSC/PBC/AIH	2.3%
Other	1.3%
Local-regional treatment, n (%)	238 (54%)
TACE	170 (71%)
RFA	51 (21%)
TACE and RFA	17 (7%)
Death	30.0%
HCC Recurrence	7.9%